7Baggers

BioNexus Gene Lab Corp Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 -2.61-0.611.383.385.377.379.3611.36Milllion

BioNexus Gene Lab Corp Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
  revenue2,553,686 2,566,848 2,377,205 2,839,575 2,575,086 2,485,101 3,028,945 3,245,271 3,575,966 3,092,171 3,449,159 11,360,428 23,471 6,541 53,049 24,173 21,645 28,088 
  cost of revenue2,199,354 2,227,134 2,008,308 2,500,349 2,275,587 2,241,779 2,695,406 2,789,722 2,887,867 2,624,564 2,866,594 9,625,056 15,253 17,315 18,726 16,499 17,020 18,822 
  gross profit354,332 339,714 368,897 339,226 299,499 243,322 333,539 455,549 688,099 467,607 582,565 1,735,372 8,218 -10,774 34,323 7,674 4,625 9,266 
  operating expenses                  
  research and development0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  sales, general and administrative                  
  total operating expenses2,881,798 611,913 419,528 461,915 364,714 381,286 298,848 254,486 315,458 327,617 240,463 278,316 70,658 55,276 110,784 63,097 73,844 69,469 
  operating income-2,527,466 -272,199 -50,631 -122,689 -65,215 -137,964 34,691 201,063 372,641 139,990 342,102 1,446,508 -59,543 -66,050 -96,145 -50,138 -69,219 -60,203 
  net income-2,608,143 -259,251 -69,066 -156,969 -77,401 -138,662 17,066 89,243 295,322 28,262 338,744 1,268,623 -60,035 -66,537 -92,577 -22,028 -70,398 -61,467 

We provide you with 20 years income statements for BioNexus Gene Lab Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BioNexus Gene Lab Corp stock. Explore the full financial landscape of BioNexus Gene Lab Corp stock with our expertly curated income statements.

The information provided in this report about BioNexus Gene Lab Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.